latest news releases from the newsroom
If P&C Insurance
If divests Marine & Energy operations for USD 30M to Norwegian Assuranceforeningen Gard
STOCKHOLM, Sweden, Oct. 28, 2003 (PRIMEZONE) -- If P&C Insurance AB (Publ) has agreed to sell the Marine & Energy business area to Gard Marine & Energy, a company to be established and jointly owned by If and the Norwegian insurance company Assuranceforeningen Gard. The agreed selling price amounts to USD 30M (SEK 230M). Through this divestment, If is streamlining its operations and reducing most of its risk exposure in the marine and energy segment. The transaction will release capital and increase the solvency ratio by approximately 3.5 percentage points.
Bookham Technology Plc
Bookham Technology Plc -- 3rd Quarter Results
OXFORDSHIRE, U.K., Oct. 28, 2003 (PRIMEZONE) -- Bookham Technology plc (LSE:BHM) (Nasdaq:BKHM), a leading provider of optical components, modules and subsystems for fiber optic communication networks, today announced results for the third quarter ended September 28, 2003.
Trintech Group Plc
Trintech Achieves Visa PED Certification on Bank-Accredited PIN Pad Terminals
LONDON and DALLAS Oct. 28, 2003 (PRIMEZONE) -- Trintech Group Plc (Nasdaq:TTPA) (Prime Standard:TTP), a leading provider of transaction management and payment infrastructure solutions, today announced that it has achieved Visa PED (PIN Entry Device) certification on its bank-accredited Smart 5000 and Compact 950 PINPad terminals. This certification follows Trintech's success in being the first company to receive acquirer approval for its integrated point-of-sale EMV Chip and PIN solution.
Urban Backstrom new CEO of Skandia Liv
STOCKHOLM, Sweden, Oct. 28, 2003 (PRIMEZONE) -- Former head of Riksbanken (the Swedish Central Bank) Urban Backstrom has been named President and CEO of Skandia Liv. He will take office on 1 November.
Investor positive toward ABB's new rights issue
STOCKHOLM, Sweden, Oct. 28, 2003 (PRIMEZONE) -- Investor's President and CEO Marcus Wallenberg made the following statement today in connection with ABB's announcement that it would carry out a rights issue of new shares:
Celltech Group plc
Celltech Achieves Milestone in Osteoporosis Collaboration with Amgen
SLOUGH, U.K., Oct. 28, 2003 (PRIMEZONE) -- Celltech Group plc (LSE:CCH) (NYSE:CLL) today announced the achievement of a milestone in its agreement with Amgen Inc. for the research, development and global commercialisation of novel treatments for osteoporosis using Celltech's proprietary antibody fragment technology, which aims to identify antibody fragments against sclerostin, a protein discovered by Celltech. Sclerostin is involved in the regulation of bone deposition, and it is believed that by inhibiting this protein, bone loss in osteoporosis patients may be reversed. Amgen and Celltech scientists have identified a high-affinity function modifying Celltech antibody for further study, triggering an undisclosed milestone payment to Celltech.